Quick Answer
BiomX Inc. reported R&D Expense of $21.29 million for fiscal year 2025.
BiomX Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $21.29M | -13.7% |
| 2024 | $24.66M | +47.7% |
| 2023 | $16.70M | +2.8% |
| 2022 | $16.24M | -28.4% |
| 2021 | $22.68M | +16.8% |
| 2020 | $19.42M | +43.9% |
| 2019 | $13.49M | +47.7% |
| 2018 | $9.13M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.12M | -15.9% | +22.1% |
| June 30, 2025 | $5.01M | -27.3% | -4.5% |
| March 31, 2025 | $5.25M | +27.9% | -27.9% |
| September 30, 2024 | $7.28M | +29.0% | +5.5% |
| June 30, 2024 | $6.90M | +80.6% | +68.0% |
| March 31, 2024 | $4.11M | -10.1% | -27.2% |
| September 30, 2023 | $5.64M | +59.5% | +47.7% |
| June 30, 2023 | $3.82M | -16.7% | -16.3% |
- BiomX Inc. showed a decrease of -13.7% in R&D Expense compared to the prior fiscal year.
- Over the 2018–2025 period, BiomX Inc.’s r&d expense has grown by 133.1% (from $9.13 million to $21.29 million).
- The most recent figure is from BiomX Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: